Kim Seung-taek received his Ph.D. in biochemistry from Iowa State University in 2004. For his postdoctoral research, he moved to Howard Hughes Medical Institute at the University of Wisconsin-Madison and studied the hepatitis B virus.
His research on the hepatitis virus continued even after he came back to Korea in 2012 to join the Yonsei Liver Center at Severance Hospital. In 2017, he became the Head of the Zoonotic Virus Laboratory at Institut Pasteur Korea and started to investigate emerging viruses (e.g., MERS-CoV, SARS-CoV-2, SFTS, Zika and dengue viruses).
Currently, his research focuses on the development of therapeutic interventions (e.g., small molecule inhibitors and therapeutic antibodies) against these emerging viruses. In addition to his research, he is also serving as a member of the Pan-Government Working Group for COVID-19 Drug & Vaccine Development and the WHO Working Groups on COVID-19 Animal Models and Serology.